June 18, 2015 | London, UK
Trilogy hosted a discussion on the challenges posed by the guideline on good pharmacovigilance practices (GVP) with a special focus on Risk Management Plans (RMPs), together with our speakers:
- John Solomon (Head of Pharmacovigilance at Sanofi)
- Dr. Lisa Chamberlain James (Senior Partner at Trilogy Writing & Consulting)